+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
Acne Drugs Global Market Report 2024 - Product Thumbnail Image

Acne Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
From
Unresectable Hepatocellular Carcinoma Global Market Report 2024 - Product Thumbnail Image

Unresectable Hepatocellular Carcinoma Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
From
From
Antiobesity Global Market Report 2024 - Product Thumbnail Image

Antiobesity Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Intrahepatic Cholangiocarcinoma (ICC)- Pipeline Insight, 2024 - Product Thumbnail Image

Intrahepatic Cholangiocarcinoma (ICC)- Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 80 Pages
  • Global
From
Cardiovascular Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Cardiovascular Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 300 Pages
  • Global
From
Prostate Cancer Therapeutics Market - Product Thumbnail Image

Prostate Cancer Therapeutics Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024 - Product Thumbnail Image

Global Cancer Tubulin Inhibitors Market & Clinical Trial Insight 2024

  • Clinical Trials
  • February 2018
  • 225 Pages
  • Global
From
Loading Indicator